Reversible dysphagia due to gabapentin-induced jaw myoclonus
Chin Med J (Engl)
.
2019 Jun 20;132(12):1485-1486.
doi: 10.1097/CM9.0000000000000271.
Authors
Chun-Him Hui
1
,
Jackson Ka-Chun Leung
2
,
Richard Shek-Kwan Chang
3
,
Yat-Fung Shea
4
Affiliations
1
Respiratory Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
2
Medical Oncology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
3
Neurology Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
4
Geriatrics Division, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, China.
PMID:
31205109
PMCID:
PMC6629332
DOI:
10.1097/CM9.0000000000000271
Abstract
Supplemental Digital Content is available in the text
Publication types
Case Reports
MeSH terms
Aged, 80 and over
Female
Gabapentin / adverse effects*
Humans
Jaw / drug effects
Jaw / pathology*
Myoclonus / chemically induced*
Myoclonus / diagnosis
Substances
Gabapentin